Freeport-McMoRan Inc vs Johnson & Johnson — how do they compare? Freeport-McMoRan Inc trades at $69.07 (market cap $96.42B), while Johnson & Johnson trades at $260.28 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 6.5× Freeport-McMoRan Inc's market cap, and Johnson & Johnson pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| FCX | JNJ | |
|---|---|---|
Market Cap | $96.42B | $626.09B |
Sector | Basic Materials | Health |
52-Week High | $71.73 | $267.24 |
52-Week Low | $35.34 | $172.78 |
Enterprise Value | $102.70B | $654.37B |
Dividend Yield | 0.87% | 2.06% |
Volume | — | 6,156,228 |
Signals from Pluang's Aura AI — not financial advice
FCX trades at $70.53, up 1.31% today, with a bullish technical signal and strong analyst support. Recent earnings beats and robust cash flow from operations highlight operational strength. The stock is near its consensus price target of $73.85, with copper market tailwinds and growth initiatives like the Grasberg ramp-up providing positive momentum.
The outlook is positive given earnings momentum and favorable copper prices, but risks include commodity price volatility and execution challenges. With a P/E of 33.76, valuation is elevated, yet growth prospects justify investor optimism. Key risks are macroeconomic sensitivity and capital expenditure demands.
Johnson & Johnson (JNJ) trades at $261.81, up 0.99% on the day and near its 52-week high. The stock exhibits bullish technical signals with strong moving average support, while fundamentals show robust profitability with a net income margin of 21.48% and consistent dividend growth. Recent earnings have mostly beaten expectations, and the company maintains a solid balance sheet with $24.52 billion in cash.
The outlook for JNJ remains positive, supported by analyst consensus and a price target of $284.50. Key opportunities include its defensive healthcare positioning and pipeline strength, though risks involve patent expirations and legal headwinds. The stock offers a stable investment with growth potential in a volatile market.
Trailing returns across standard periods
Latest headlines on both assets
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →